CoChat

Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state

Feng, Bo, LaPerle, Jennnifer L, Chang, George, Varma, Manthena VS · 2010 · Expert Opinion on Drug Metabolism & Toxicology
Cited by 105

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

IMPORTANCE OF THE FIELD: Kidney plays a key role in the elimination of xenobiotics and metabolic products from the body, where renal clearance is determined by glomerular filtration, tubular secretion and reabsorption processes. The proximal tubule of the nephron is equipped with multi-specificity uptake and efflux transporters for the secretion of a broad range of xenobiotics, while the compound physicochemical space drives the tubular reabsorption. Due to involvement of transporters, renal clearance is possibly associated with renal drug-drug interactions (DDIs) in clinical situations. Nevertheless, renal insufficiency in diseased population is associated with altered transporter activity and evidently affects the pharmacokinetics of both renally and non-renally cleared compounds. Thus, early information on renal clearance is critical for successful development of compounds in certain chemical space. AREAS COVERED IN THIS REVIEW: This review provides updated information on the influence of physicochemical properties and the relevance of transporters in renal clearance and the associated drug interactions. In silico tools to predict the renal clearance at the discovery stage along with the potential alterations in drug disposition in the renal disease state are discussed with preclinical and clinical examples. WHAT THE READER WILL GAIN: The review provides comprehensive knowledge with recent examples to moderate renal disposition concerns in the drug discovery and development settings. TAKE HOME MESSAGE: Consideration of clearance pathways early in the discovery process has become critical for successful development of compounds. Although significant progress has been made in elucidating the physicochemical drivers and biochemical processes for this pathway, the predictive ability remains a challenge. Furthermore, development of renally cleared compounds should progress with a clear understanding of possible issues including transporter-mediated DDI and disease state.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1517/17425255.2010.482930

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 105

Metadata

Authors
Feng, B., LaPerle, J. L., Chang, G., & Varma, M. V.
Venue
Expert Opinion on Drug Metabolism & Toxicology
Published
2010-05-03
Volume
6
Issue
8
Pages
939-952
ISSN
  • 1742-5255 (ISSN-L)
  • 1744-7607
OpenAlex
W2154165320
Cited by
105
References
5
FWCI
2.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state. https://app.cochat.ai/papers/10.1517/17425255.2010.482930
The paper
Feng, B., LaPerle, J. L., Chang, G., & Varma, M. V. (2010). Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1517/17425255.2010.482930

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.